Evexia Lifecare Limited (BOM:524444)
India · Delayed Price · Currency is INR 1.320
-0.050 (-3.65%)
At close: Aug 21, 2026
Evexia Lifecare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 2,478 | 4,900 | 1,628 | 1,010 | 1,784 | 9,089 | |
Market Cap Growth | -41.85% | 201.00% | 61.25% | -43.40% | -80.38% | 76.59% |
Enterprise Value | 14,682 | 9,917 | 8,613 | 1,104 | 1,845 | 9,010 |
Last Close Price | 1.32 | 2.61 | 2.45 | 1.63 | 2.88 | 14.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | - | 1187.84 | 118.03 | 151.42 | 206.92 | 708.62 |
PS Ratio | - | 5.66 | 2.89 | 1.45 | 2.36 | 8.52 |
PB Ratio | - | 1.07 | 1.26 | 1.12 | 2.22 | 11.41 |
P/TBV Ratio | - | 1.07 | 1.26 | 1.12 | 2.22 | 11.42 |
P/FCF Ratio | - | - | 9.71 | - | - | 599.56 |
P/OCF Ratio | - | - | 9.57 | - | - | 532.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
EV/Sales Ratio | - | 11.45 | 15.31 | 1.59 | 2.44 | 8.45 |
EV/EBITDA Ratio | - | 600.64 | 472.46 | 189.00 | 76.32 | - |
EV/EBIT Ratio | - | 838.38 | 612.27 | 578.37 | 83.49 | - |
EV/FCF Ratio | - | - | 51.39 | - | - | 594.34 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Debt / Equity Ratio | - | 0.81 | 5.26 | 7.81 | 0.07 | 0.09 |
Debt / EBITDA Ratio | - | 226.83 | 373.93 | 1206.52 | 2.39 | - |
Debt / FCF Ratio | - | - | 40.67 | - | - | 4.47 |
Net Debt / Equity Ratio | - | 0.81 | 5.26 | 7.80 | 0.05 | 0.08 |
Net Debt / EBITDA Ratio | - | 226.45 | 373.52 | 1205.71 | 1.76 | -0.09 |
Net Debt / FCF Ratio | - | -84.71 | 40.63 | -125.93 | -0.52 | 4.13 |
Asset Turnover | - | 0.10 | 0.07 | 0.14 | 0.56 | 0.58 |
Inventory Turnover | - | 52.00 | 32.56 | 39.10 | 30.45 | 52.76 |
Quick Ratio | - | 1.52 | 1.44 | 0.68 | 0.53 | 0.88 |
Current Ratio | - | 1.66 | 1.51 | 1.86 | 2.19 | 2.08 |
Return on Equity (ROE) | - | 0.14% | 1.26% | 0.78% | 1.08% | 1.62% |
Return on Assets (ROA) | - | 0.08% | 0.10% | 0.02% | 1.03% | -24.03% |
Return on Invested Capital (ROIC) | - | 0.07% | 0.13% | 0.02% | 1.03% | -54.99% |
Return on Capital Employed (ROCE) | - | 0.10% | 0.20% | 0.00% | 2.30% | -78.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Earnings Yield | - | 0.08% | 0.85% | 0.66% | 0.48% | 0.14% |
FCF Yield | - | -0.90% | 10.30% | -5.54% | -4.61% | 0.17% |
Buyback Yield / Dilution | -29.29% | -129.30% | -6.56% | -7.28% | - | - |